High-affinity pan-specific monoclonal antibodies that target cysteinyl leukotrienes and show efficacy in an acute model of colitis

Dahlén, 1980, Leukotrienes are potent constrictors of human bronchi, Nature., 288, 484, 10.1038/288484a0 Kim, 1995, Levels of peptidoleukotriene E4 are elevated in active Crohn's disease, J. Pediatr. Gastroenterol. Nutr., 20, 403, 10.1097/00005176-199505000-00005 Samuelsson, 1980, Leukotrienes and slow reacting substance of anaphylaxis (SRS-A), Allergy., 35, 375, 10.1111/j.1398-9995.1980.tb01782.x Hammerström, 1980, Detection of leukotriene A4 as an intermediate in the biosynthesis of leukotrienes C4 and D4, FEBS Lett., 122, 83, 10.1016/0014-5793(80)80407-8 Rådmark, 1980, Leukotriene A4: enzymatic conversion to leukotriene C4, Biochem. Biophys. Res. Commun., 96, 1679, 10.1016/0006-291X(80)91367-4 Lee, 1983, Conversion of leukotriene D4 to leukotriene E4 by a dipeptidase released from the specific granule of human polymorphonuclear leucocytes, Immunology., 48, 27 Han, 2002, Gamma-glutamyl leukotrienase, a novel endothelial membrane protein, is specifically responsible for leukotriene D4 formation in vivo, Am. J. Pathol., 161, 481, 10.1016/S0002-9440(10)64204-6 Bankova, 2016, Leukotriene E4 elicits respiratory epithelial cell mucin release through the G-protein-coupled receptor, GPR99, Proc. Natl. Acad. Sci. USA., 113, 6242, 10.1073/pnas.1605957113 Kanaoka, 2013, Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand, J. Biol. Chem., 288, 10967, 10.1074/jbc.C113.453704 Weichman, 1985, Differentiation of the mechanisms by which leukotrienes C4 and D4 elicit contraction of the guinea pig trachea, Prostaglandins., 29, 547, 10.1016/0090-6980(85)90079-6 Lynch, 1999, Characterization of the human cysteinyl leukotriene CysLT1 receptor, Nature., 399, 789, 10.1038/21658 Heise, 2000, Characterization of the human cysteinyl leukotriene 2 receptor, J. Biol. Chem., 275, 30531, 10.1074/jbc.M003490200 Kanaoka, 2014, Cysteinyl leukotrienes and their receptors; emerging concepts, Allergy Asthma Immunol. Res., 6, 288, 10.4168/aair.2014.6.4.288 Beller, 2004, Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice, J. Biol. Chem., 279, 46129, 10.1074/jbc.M407057200 Oyoshi, 2012, Eosinophil-derived leukotriene C4 signals via type 2 cysteinyl leukotriene receptor to promote skin fibrosis in a mouse model of atopic dermatitis, Proc. Natl. Acad. Sci. USA., 109, 4992, 10.1073/pnas.1203127109 Ye, 2013, IgBLAST: an immunoglobulin variable domain sequence analysis tool, Nucleic Acids Res., 41, W34, 10.1093/nar/gkt382 Obmolova, 2010, Promoting crystallization of antibody-antigen complexes via microseed matrix screening, Acta Crystallogr. D Biol. Crystallogr., 66, 927, 10.1107/S0907444910026041 Otwinowski, 1997, Processing of X-ray diffraction data collected in oscillation mode, 307 McCoy, 2007, Phaser crystallographic software, J. Appl. Crystallogr., 40, 658, 10.1107/S0021889807021206 Winn, 2011, Overview of the CCP4 suite and current developments, Acta Crystallogr. D Biol. Crystallogr., 67, 235, 10.1107/S0907444910045749 Murshudov, 1997, Refinement of macromolecular structures by the maximum-likelihood method, Acta Crystallogr. D Biol. Crystallogr., 53, 240, 10.1107/S0907444996012255 Emsley, 2010, Features and development of Coot, Acta Crystallogr. D Biol. Crystallogr., 66, 486, 10.1107/S0907444910007493 Adams, 2010, PHENIX: a comprehensive Python-based system for macromolecular structure solution, Acta Crystallogr. D Biol. Crystallogr., 66, 213, 10.1107/S0907444909052925 Chen, 2010, MolProbity: all-atom structure validation for macromolecular crystallography, Acta Crystallogr. D Biol. Crystallogr., 66, 12, 10.1107/S0907444909042073 DeLano, 2002 Reinke, 1991, A monoclonal antibody against the sulfidopeptide leukotrienes LTC4, LTD4 and LTE4, Biochim. Biophys. Acta., 1081, 274, 10.1016/0005-2760(91)90282-M Orning, 1985, In vivo metabolism of leukotriene C4 in man: urinary excretion of leukotriene E4, Biochem. Biophys. Res. Commun., 130, 214, 10.1016/0006-291X(85)90404-8 Tsodikov, 2002, Novel computer program for fast exact calculation of accessible and molecular surface areas and average surface curvature, J. Comput. Chem., 23, 600, 10.1002/jcc.10061 Pozharski, 2005, Diversity in hapten recognition: structural study of an anti-cocaine antibody M82G2, J. Mol. Biol., 349, 570, 10.1016/j.jmb.2005.03.080 Kabat, 1991 Griswold, 1991, Induction of plasma exudation and inflammatory cell infiltration by leukotriene C4 and leukotriene B4 in mouse peritonitis, Inflammation., 15, 251, 10.1007/BF00917310 Hua, 1985, Leukotrienes C4, D4 and E4 cause widespread and extensive plasma extravasation in the guinea pig, Naunyn Schmiedebergs Arch. Pharmacol., 330, 136, 10.1007/BF00499906 Chassaing, 2014, Dextran sulfate sodium (DSS)-induced colitis in mice, Curr. Protoc. Immunol., 104, 10.1002/0471142735.im1525s104 Okayasu, 1990, A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice, Gastroenterology., 98, 694, 10.1016/0016-5085(90)90290-H Syslová, 2013, Immunomagnetic molecular probe with UHPLC-MS/MS: a promising way for reliable bronchial asthma diagnostics based on quantification of cysteinyl leukotrienes, J. Pharm. Biomed. Anal., 81–82, 108, 10.1016/j.jpba.2013.03.026 Stanke-Labesque, 2008, Urinary leukotriene E4 excretion: a biomarker of inflammatory bowel disease activity, Inflamm. Bowel Dis., 14, 769, 10.1002/ibd.20403 Davidson, 1995, Elevated urinary leukotriene E4 in chronic lung disease of extreme prematurity, Am. J. Respir. Crit. Care Med., 151, 841, 10.1164/ajrccm/151.3_Pt_1.841 Hua, 2006, Evaluation and interference of serum and skin lesion levels of leukotrienes in patients with eczema, Prostaglandins Leukot. Essent. Fatty Acids., 75, 51, 10.1016/j.plefa.2006.02.007 Zhou, 2011, Circulating LTD4 in patients with hepatocellular carcinoma, Tumour Biol., 32, 139, 10.1007/s13277-010-0107-8 Israel, 1993, The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma, Ann. Intern. Med., 119, 1059, 10.7326/0003-4819-119-11-199312010-00001 Antoine, 1991, Development of enzyme immunoassays for leukotrienes using acetylcholinesterase, Biochim. Biophys. Acta., 1075, 162, 10.1016/0304-4165(91)90247-E Matsumoto, 1993, Immunoaffinity purification of prostaglandin E2 and leukotriene C4 prior to radioimmunoassay: application to human synovial fluid, Ann. Clin. Biochem., 30, 60, 10.1177/000456329303000110 Kawakami, 2017, The Y54(L)W mutation of anti-leukotriene C4 single-chain antibody increases affinity to leukotriene E4, J. Biochem., 161, 79, 10.1093/jb/mvw055 Jablonka, 2016, Structure and ligand-binding mechanism of a cysteinyl leukotriene-binding protein from a blood-feeding disease vector, ACS Chem. Biol., 11, 1934, 10.1021/acschembio.6b00032 Fleming, 2011, Biochemical and structural characterization of lysophosphatidic acid binding by a humanized monoclonal antibody, J. Mol. Biol., 408, 462, 10.1016/j.jmb.2011.02.061 Wojciak, 2009, The crystal structure of sphingosine-1-phosphate in complex with a Fab fragment reveals metal bridging of an antibody and its antigen, Proc. Natl. Acad. Sci. USA., 106, 17717, 10.1073/pnas.0906153106